| Record ID | marc_columbia/Columbia-extract-20221130-012.mrc:137578235:1803 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-012.mrc:137578235:1803?format=raw |
LEADER: 01803cam a2200397Ia 4500
001 5650945
005 20221121201041.0
008 060620t20062006sz b 000 0 eng d
020 $a9241546956
024 3 $a9789241546959
035 $a(OCoLC)ocm70143001
035 $a(NNC)5650945
035 $a5650945
040 $aPIT$cPIT
090 $aRA644.T7$bG85 2006
096 $aWF 310 G946 2006
245 00 $aGuidelines for the programmatic management of drug-resistant tuberculosis.
260 $aGeneva :$bWorld Health Organization,$c[2006], ©2006.
300 $ax, 174 pages ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aEditors-in-chief: Michael Rich [and others]--P. iv.
500 $a"WHO/HTM/TB/2006.361".
504 $aIncludes bibliographical references.
650 0 $aTuberculosis$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85138409
650 0 $aTuberculosis$xPrevention.$0http://id.loc.gov/authorities/subjects/sh85138425
650 0 $aAntitubercular agents.$0http://id.loc.gov/authorities/subjects/sh85005784
650 0 $aHIV infections$xChemotherapy.
650 2 $aTuberculosis, Multidrug-Resistant$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D018088Q000188
650 2 $aTuberculosis, Multidrug-Resistant$xprevention & control.$0https://id.nlm.nih.gov/mesh/D018088Q000517
650 2 $aAntitubercular Agents.$0https://id.nlm.nih.gov/mesh/D000995
650 2 $aHIV Infections$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D015658Q000188
655 7 $aGuideline.$2mesh$0https://id.nlm.nih.gov/mesh/D016431
700 1 $aRich, Michael.$0http://id.loc.gov/authorities/names/n2018051380
710 2 $aWorld Health Organization.$0http://id.loc.gov/authorities/names/n79059041
852 00 $boff,hsl$hRA644.T7$iG85 2006